SITARI PHARMACEUTICALS
Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.
SITARI PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Intellectual Property Pharmaceutical Robotics
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Total Funding:
10 M USD
Similar Organizations
Actinogen Medical
Actinogen Medical is biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
ERS Genomics
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Reactive Medical Labs
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications.
Somai Pharmaceuticals Ltd
Somai is a European pharmaceutical and biotech company concentrating on cannabinoid-containing pharmaceutical medicines.
Visionary Pharmaceuticals
Visionary Pharmaceuticals is a biotechnology company developing first-in-class drugs for unmet medical needs in cancer and inflammation.
Current Employees Featured
Founder
Investors List
GlaxoSmithKline
GlaxoSmithKline investment in Series A - Sitari Pharmaceuticals
Avalon Ventures
Avalon Ventures investment in Series A - Sitari Pharmaceuticals
More informations about "Sitari Pharmaceuticals" on Search Engine
GSK buys celiac startup Sitari 6 years after founding it …
Sep 11, 2019 Sitari, a preclinical-stage biotech, is developing inhibitors of the TG2 …See details»
Sitari Pharmaceuticals - Crunchbase Company Profile
Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop …See details»
GSK to buy Sitari Pharmaceuticals from Avalon Ventures
UK-based pharmaceutical company GlaxoSmithKline (GSK) has signed a definitive …See details»
GSK Buys Celiac Startup Sitari 6 Years After Founding It With …
Sep 16, 2019 GlaxoSmithKline has struck a deal to buy Sitari Pharmaceuticals, the first …See details»
GSK to Acquire Celiac-Focused Sitari Pharmaceuticals
Sep 11, 2019 Sitari, which was incubated at COI Pharmaceuticals, the Community of …See details»
AVALON VENTURES, GSK LAUNCH BIOTECH
Nov 22, 2013 Avalon Ventures and GSK have contributed a total of $10 million to …See details»
Sitari Pharmaceuticals, First Company Launched …
Nov 22, 2013 Sitari Pharmaceuticals is targeting the Transglutaminase 2 (TG2) …See details»
Avalon Ventures and COI Pharmaceuticals Announce …
Sep 11, 2019 GSK to acquire Sitari Pharmaceuticals, which has been developing a …See details»
GlaxoSmithKline’s Acquisition Of Sitari Pharmaceuticals: …
Sep 13, 2019 Sitari is known for developing a novel treatment for celiac disease and it …See details»
Avalon Ventures-GlaxoSmithKline Launch Sitari Pharm
Sitari Pharmaceuticals is targeting the Transglutaminase 2 (TG2) pathway for the …See details»
Avalon Ventures and COI Pharmaceuticals Announce First …
May 23, 2016 Sitari Pharmaceuticals, which is developing novel treatments for celiac …See details»
Sitari Pharmaceuticals Company Profile: Valuation, Investors ...
Nov 22, 2013 Description. Operator of a biotechnology company intended to develop …See details»
Sitari Pharmaceuticals acquired by GlaxoSmithKline - Crunchbase
Overview. Acquired Organization: Sitari Pharmaceuticals Sitari Pharmaceuticals is a …See details»
Avalon Ventures and COI Pharmaceuticals Announce Acquisition …
Sitari has been developing a novel treatment for celiac disease and was the first …See details»
Sitari Pharmaceuticals - Funding, Financials, Valuation & Investors
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple …See details»
Avalon Ventures and COI Pharmaceuticals announce acquisition …
Sitari has been developing a novel treatment for celiac disease and was the first …See details»
Sitari Pharmaceuticals - Products, Competitors, Financials, …
About Sitari Pharmaceuticals. Sitari Pharma is developing treatments for celiac disease, …See details»
Sitari Pharmaceuticals | VentureRadar
Sitari Pharmaceuticals | VentureRadar. Location: USA. Acquired. "Sitari …See details»
Avalon Ventures and COI Pharmaceuticals Announce Acquisition …
Sep 11, 2019 Sitari has been developing a novel treatment for celiac disease and was …See details»
Sitari Pharmaceuticals - Updates, News, Events, Signals & Triggers
Sep 11, 2019 Sitari Pharmaceuticals is a biotechnology company developing …See details»